Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases-Reference-Cited by-同舟云学术

Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases

Published:2017-03-06 Issue:3 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bahiru Ehete¹,de Cates Angharad N²,Farr Matthew RB²,Jarvis Morag C²,Palla Mohan³,Rees Karen²,Ebrahim Shah⁴,Huffman Mark D⁵

Affiliation:

1. Northwestern University; Internal Medicine; Division of Cardiology; 201 E. Huron St. Galter 19-100 Chicago Illinois USA 60611

2. Warwick Medical School, University of Warwick; Division of Health Sciences; Coventry UK CV4 7AL

3. Wayne State University; Department of Medicine; 540 E Canfield St Detroit Michigan USA 48201

4. London School of Hygiene & Tropical Medicine; Department of Non-communicable Disease Epidemiology; Keppel Street London UK WC1E 7HT

5. Northwestern University Feinberg School of Medicine; Departments of Preventive Medicine and Medicine (Cardiology); 680 N. Lake Shore Drive, Suite 1400 Chicago IL USA 60611

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009868.pub3/epdf/full

Reference217 articles.

1. Proactive multifactorial intervention strategy reduces the risk of cardiovascular disease estimated with region-specific risk assessment models in Pacific Asian patients participating in the CRUCIAL trial;Cho;Journal of Korean Medical Science,2013

2. Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis;Cho;Vascular Health and Risk Management,2014

3. Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial;Hradec;Current Medical Research and Opinion,2013

4. Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (< 65 years) and older (≥ 65 years) patients in the CRUCIAL trial;Kim;Current Medical Research and Opinion,2013

5. Changes in calculated coronary heart disease risk using proactive multifactorial intervention versus continued usual care in Latin-American and non-Latin-American patients enrolled in the CRUCIAL trial;Pavia;Current Medical Research and Opinion,2012

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypill use for the prevention of cardiovascular disease: A position paper;Revista Portuguesa de Cardiologia;2023-10

2. The cardiovascular polypill as baseline treatment improves lipid profile and blood pressure regardless of body mass index in patients with cardiovascular disease. The Bacus study;PLOS ONE;2023-08-25

3. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes;European Heart Journal;2023-08-25

4. Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries;JAMA;2023-08-22

5. Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens;Advanced Healthcare Materials;2023-08-13